Treace Medical Concepts, Inc. provided revenue guidance for the year 2024. For the period, the company expects revenue to be $220 million to $225 million, which represents approximately 18% to 20% growth over full-year 2023 revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.65 USD | +2.40% | -4.05% | -16.47% |
Mar. 25 | Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction | MT |
Feb. 27 | Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.47% | 644M | |
+72.92% | 12.38B | |
-19.68% | 7.92B | |
+16.20% | 7.2B | |
+6.78% | 5.84B | |
+7.49% | 5.07B | |
+23.97% | 4.53B | |
-19.38% | 3.88B | |
-41.54% | 2.23B | |
+1.24% | 2.02B |
- Stock Market
- Equities
- TMCI Stock
- News Treace Medical Concepts, Inc.
- Treace Medical Concepts, Inc. Provides Revenue Guidance for the Year 2024